前列腺切除术后放疗的生活质量:TROG 08.03 RAVES随机对照试验子研究
该研究为TROG 08.03 RAVES随机试验的计划二次分析,比较根治性前列腺切除术后辅助放疗(aRT)与挽救性放疗(sRT)对患者报告生活质量的影响。结果显示aRT组肠道症状临床重要变化比例更高,5年时严重尿失禁自报率16% vs 2%(p=0.01),但aRT与接受放疗的sRT组在泌尿、肠道及性功能方面无显著差异;sRT时机对生活质量影响有限。
要点
- 辅助放疗组1-5年肠道症状临床重要变化比例高于未放疗的挽救组。
- 5年时辅助放疗组严重尿失禁自报率16%,未放疗组2%(p=0.01)。
- 辅助放疗与接受放疗的挽救组在泌尿、肠道、性功能无显著差异。
核心结论
- 前列腺切除术后放疗患者较未需放疗者报告轻度肠道症状恶化及长期尿失禁风险增加。
- 挽救性放疗的时机对患者报告生活质量关联有限。
研究设计与样本
- 随机对照试验的计划二次分析,比较辅助放疗与前列腺特异性抗原>0.2 ng/ml时给予的挽救性放疗。
- 生活质量采用EORTC QLQ-C30和QLQ-PR25测量,临床重要变化定义为较基线下降>0.5个标准差。
- 辅助放疗组166例。
主要发现
- 辅助放疗组1-5年报告肠道症状临床重要变化比例高于未接受放疗的挽救组。
- 5年时辅助放疗组16%自报严重尿失禁,未放疗组2%(p=0.01)。
- 辅助放疗组与接受放疗的挽救组在1-5年泌尿、肠道、性功能无统计学显著差异。
- 回归分析中挽救性放疗时机对生活质量无显著影响。
临床怎么用
- 与患者沟通前列腺切除术后放疗时,应告知肠道症状轻度恶化及长期尿失禁风险。
- 辅助放疗与挽救性放疗的选择可更多考虑肿瘤学获益,因时机对生活质量影响有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVE: There is continued uncertainty about whether the timing of radiotherapy (RT) after radical prostatectomy (RP) affects toxicity. This study assesses differences in patient-reported quality of life (QOL) for patients randomized to adjuvant RT (aRT) or salvage RT (sRT) after RP. METHODS: This is a planned secondary analysis of a randomized trial comparing aRT with sRT delivered if prostate-specific antigen increased to >0.2 ng/ml. QOL was measured using the EORTC (European Organization for Research and Treatment of Cancer) tools QLQ-C30 (Core Quality of Life Questionnaire) and QLQ-PR25 (Quality of Life Questionnaire - Prostate Cancer). The minimal clinically important change (MCIC) was a decline in QOL of >0.5 standard deviations from baseline. KEY FINDINGS AND LIMITATIONS: Participants in the aRT arm (n = 166) had a higher proportion of patients reporting an MCIC in bowel symptoms at 1 to 5 yr after randomization compared to patients in the sRT arm who did not receive RT. At 5 yr, 16% of the patients in the aRT arm self-reported severe urinary incontinence compared to 2% in the no RT group (p = 0.01). When comparing patients in the aRT group to those in the sRT group who did receive RT, there were no statistically significant differences in urinary symptoms, bowel symptoms, or sexual functioning from 1 to 5 yr after RT. On regression analysis, the timing of sRT had no significant effect on QOL. CONCLUSIONS AND CLINICAL IMPLICATIONS: Patients receiving postprostatectomy RT reported a minor worsening in bowel symptoms and an increased risk of long-term urinary incontinence compared to patients who did not require RT. Overall, the timing of sRT has a limited association with patient-reported QOL.
引用
- Smith J, Duchesne GM, Kneebone A, et al. Quality of Life After Postprostatectomy Radiotherapy: A TROG 08.03 RAVES Randomized Controlled Trial Substudy. Eur Urol Oncol. 2026. PMID: 42425869. doi:10.1016/j.euo.2026.06.014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。